Asia Pacific Deep Brain Stimulation Devices Market, by Applications, by End User, by Country, Industry Analysis and Forecast, 2019 - 2025

The Asia Pacific Deep Brain Stimulation Devices Market is expected to witness market growth of 17.6% CAGR during the forecast period (2019-2025).

Asia Pacific is projected to see the fastest market growth due to the growing demand in countries like Japan, China and India. The rising disposable income leading to higher spending on healthcare is expected to also support growth in the region. In addition, increasing awareness of various neurological disorders such as epilepsy, critical tremors and Parkinson's disease is expected to fuel Asia Pacific's demand for DBS. Another major factor driving growth in the area is the growing number of medical settings such as specialty clinics and multispecialty hospitals.

During the past 4 decades the field of stereotactic and functional neurosurgery and DBS has expanded rapidly. With advancements in high-resolution imaging, including tractography and functional MRI, identification of individual nuclei or tracts has become more accurate. Such technological advancements also provide guidelines for intraoperative imaging and confirmation of the targets. Technological developments have also been made inside the unit. For standard PD patients the internal pulse generators (IPGs) have a battery life of about 4 years.

Additionally, there are transcutaneous, rechargeable IPGs. With advancements in stimulation programming, multiple options are critical to be able to provide. Today, there's the potential to provide stimulus paradigms interleaving. Modern IPGs can now provide programmed stimulation paradigms as well as store data from leads themselves collected from the electrode. Implanted monitoring systems have opened the way for more neurological disease studies and the underlying electrophysiological changes that arise in these states.

Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into China, India, Japan, Australia, South Korea, Singapore, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.

Scope of the Study

Market Segmentation:

By Application

• Bronchoscopy
• GI endoscopy
• ENT Endoscopy
• Urologic endoscopy
• Arthroscopy and
• Others

By End Use

• Diagnostic Centers
• Clinics
• Hospitals

By Applications

• Parkinson's disease
• Epilepsy
• Essential Tremor
• Dystonia
• Obsessive Compulsive Disorder and
• Other Applications

By End User

• Neurological Clinics
• Ambulatory Surgical Centers
• Hospital and
• Others

By Country

• China
• India
• Japan
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Companies Profiled

• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Aleva Neurotherapeutics SA
• Functional Neuromodulation, Ltd.
• Beijing PINS Medical Co., Ltd.
• NeuroPace, Inc.
• Nevro Corporation
• Neuronetics, Inc.
• Fisher Wallace Laboratories, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free